Profile data is unavailable for this security.
About the company
China Shineway Pharmaceutical Group Limited is an investment holding company principally engaged in the research and development, manufacture and trading of modern Chinese medicines. Its main products include injections, soft capsules and granules. The Company’s subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.
- Revenue in HKD (TTM)4.52bn
- Net income in HKD1.19bn
- Incorporated2002
- Employees3.23k
- LocationChina Shineway Pharmaceutical Group LtdLuanchengSHIJIAZHUANG 051430ChinaCHN
- Phone+86 31 188030066
- Fax+86 31 188030088
- Websitehttp://www.shineway.com.hk
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Recbio Technology Co Ltd | 0.00 | -589.32m | 4.00bn | 507.00 | -- | 4.42 | -- | -- | -1.23 | -1.23 | 0.00 | 1.88 | 0.00 | -- | -- | 0.00 | -25.33 | -- | -32.84 | -- | -- | -- | -- | -- | 0.9619 | -- | 0.4548 | -- | -- | -- | 20.86 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 773.35m | 66.40m | 4.08bn | 777.00 | 58.44 | 2.60 | 28.98 | 5.28 | 0.1304 | 0.1304 | 1.52 | 2.94 | 0.3069 | 1.10 | 2.60 | 951,228.60 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3369 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -300.75m | 4.30bn | 148.00 | -- | 4.27 | -- | -- | -1.49 | -1.49 | 0.00 | 5.01 | 0.00 | -- | -- | 0.00 | -23.80 | -- | -25.44 | -- | -- | -- | -- | -- | 5.91 | -- | 0.0296 | -- | -- | -- | 65.62 | -- | -- | -- |
| Ocumension Therapeutics | 333.36m | -346.72m | 4.54bn | 477.00 | -- | 1.30 | -- | 13.62 | -0.529 | -0.529 | 0.5084 | 4.29 | 0.103 | 2.40 | 2.48 | 750,810.70 | -10.71 | -38.78 | -11.55 | -41.47 | 58.29 | 62.30 | -104.01 | -975.82 | 5.00 | -- | 0.0055 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 1.88bn | -40.61m | 6.24bn | 2.65k | -- | 1.31 | -- | 3.31 | -0.0044 | -0.0044 | 0.2031 | 0.5096 | 0.1506 | 0.894 | 3.90 | 656,321.60 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.50 | -- | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.39bn | 699.17m | 6.44bn | 4.01k | 9.21 | 0.8451 | 4.61 | 0.872 | 0.5459 | 0.5459 | 5.77 | 5.95 | 0.5026 | 0.9881 | 5.22 | 1,801,600.00 | 7.42 | 7.68 | 11.69 | 12.32 | 40.97 | 43.50 | 14.76 | 16.11 | 2.30 | -- | 0.1968 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
| Beijing Tong Ren Tang Chinese Medicine | 1.38bn | 494.14m | 6.66bn | 779.00 | 13.48 | 1.75 | 10.78 | 4.84 | 0.5903 | 0.5903 | 1.64 | 4.55 | 0.3284 | 0.3554 | 3.62 | 1,725,133.00 | 12.72 | 16.71 | 14.09 | 18.75 | 72.06 | 69.88 | 38.72 | 40.72 | 9.55 | -- | 0.0327 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| China Shineway Pharmaceutical Group Ltd | 4.52bn | 1.19bn | 6.90bn | 3.23k | 5.31 | 0.8751 | 5.03 | 1.53 | 1.57 | 1.57 | 5.98 | 9.53 | 0.4476 | 1.28 | 5.26 | 1,314,640.00 | 11.76 | 8.03 | 15.47 | 9.77 | 75.21 | 74.55 | 26.27 | 17.87 | 3.14 | -- | 0.0457 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Consun Pharmaceutical Group Ltd | 2.94bn | 898.58m | 7.27bn | 3.18k | 7.69 | 1.82 | 7.39 | 2.47 | 1.11 | 1.11 | 3.65 | 4.71 | 0.5209 | 2.00 | 12.89 | 941,026.40 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 5.95bn | 1.77bn | 8.10bn | 4.89k | 4.57 | 0.8696 | 3.94 | 1.36 | 2.01 | 2.01 | 6.76 | 10.58 | 0.4272 | 2.50 | 3.74 | 1,288,911.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 50.79 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| AIM Vaccine Co Ltd | 1.27bn | -1.28bn | 8.34bn | 1.56k | -- | 2.22 | -- | 6.56 | -1.06 | -1.06 | 1.05 | 3.11 | 0.1462 | 0.6325 | 1.10 | 783,376.00 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.78bn | 827.74m | 9.48bn | 5.23k | 11.45 | 0.6777 | 5.69 | 1.40 | 0.22 | 0.22 | 1.80 | 3.72 | 0.236 | 2.44 | 3.02 | 1,287,073.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
Data as of Nov 26 2024. Currency figures normalised to China Shineway Pharmaceutical Group Ltd's reporting currency: Hong Kong Dollar HKD
5.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lancelot Asset Management ABas of 30 Jun 2023 | 11.50m | 1.39% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 11.19m | 1.35% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 7.21m | 0.87% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 5.80m | 0.70% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 2.53m | 0.31% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 1.88m | 0.23% |
| BlackRock Advisors (UK) Ltd.as of 08 Nov 2024 | 1.51m | 0.18% |
| Allianz Global Investors GmbHas of 31 Jul 2024 | 1.18m | 0.14% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2024 | 1.15m | 0.14% |
| TIAA-CREF Investment Management LLCas of 31 Aug 2024 | 938.00k | 0.11% |
More ▼
Data from 30 Jun 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
